Indian Journal of Pharmacology Home 

LETTER TO THE EDITOR
[Download PDF]
Year : 2019  |  Volume : 51  |  Issue : 6  |  Page : 416--417

Fluorescence spectra of chloroquine suspension: A probable tool for quality assessment of the most common antimalarial in a user-friendly manner

Sumanpreet Kaur1, Nikhil Prasad2, Abhikarsh Srivastava2, Monu Kumari1, Sukhpreet Singh1, Deepak Kumar1, Rajasris Bhattacharyya1, Dibyajyoti Banerjee1,  
1 Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, Haryana, India
2 Department of Science, Govt. PG College, Panchkula, Haryana, India

Correspondence Address:
Prof. Dibyajyoti Banerjee
Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh - 160 012
India




How to cite this article:
Kaur S, Prasad N, Srivastava A, Kumari M, Singh S, Kumar D, Bhattacharyya R, Banerjee D. Fluorescence spectra of chloroquine suspension: A probable tool for quality assessment of the most common antimalarial in a user-friendly manner.Indian J Pharmacol 2019;51:416-417


How to cite this URL:
Kaur S, Prasad N, Srivastava A, Kumari M, Singh S, Kumar D, Bhattacharyya R, Banerjee D. Fluorescence spectra of chloroquine suspension: A probable tool for quality assessment of the most common antimalarial in a user-friendly manner. Indian J Pharmacol [serial online] 2019 [cited 2020 Jun 4 ];51:416-417
Available from: http://www.ijp-online.com/text.asp?2019/51/6/416/276046


Full Text



Sir,

Chloroquine is a popular drug used in the treatment of malaria. Due to its good safety profile, it can be used in pregnant mothers and children. Furthermore, high elimination time of the drug provides long posttreatment preventive effect.[1] However, the poor or substandard quality of chloroquine is a worldwide concern which imposes life at risk and contributes toward the drug resistance.[2],[3] Therefore, quality assessment of chloroquine is of much concern.[4]

In the market, chloroquine is commonly available as a suspension for use in the pediatric population and tablets for use in adults. We feel that strict quality assurance of suspension is warranted as it is used in the pediatric population.

In this context, we have studied the fluorescence emission spectra of chloroquine diphosphate (MP Biomedicals Catalog No. 193919, 10 mg/ml in distilled water) at λEx 300 and found that chloroquine diphosphate in distilled water gives fluorescence emission in the range of 330–400 nm [Figure 1]a. Similarly, the fluorescence emission spectra of chloroquine phosphate suspension containing 10 mg/ml chloroquine (Lariago manufactured by Ipca Laboratories Ltd. Sejavta, Ratlam 457002. Batch No. GFA 018045R) were also studied [Figure 1]b. The spectrum of distilled water is given in [Figure 1]c. TECAN Infinite 200 Pro M PLEX multimode reader is used throughout the study setting the instrument in default mode. The chloroquine suspension contains sunset yellow, which is a synthetic food color. The sunset yellow is a fluorescent material which, when excited (λEx 310–410 nm), gives emission at 592 nm.[5]{Figure 1}

We have observed that outside the fluorescence emission range of chloroquine and sunset yellow, the suspension shows a typical pattern of emission when excited at 300 nm [Figure 1]b. However, in pure chloroquine and the suspension when excited at 300 nm, maximum emission is noted at 357 ± 20 nm.

It is interesting to note that at λEx 300 nm/λEm 357 nm, the fluorescent intensity increases linearly with increasing concentration of chloroquine suspension in distilled water (up to 0.625 mg/ml) [Figure 1]d. However, at higher concentration of chloroquine, the fluorescence intensity follows the logarithmic curve pattern [Figure 1]e.

We feel that the addition of sunset yellow in the suspension is the causative factor for deviation of the spectra of chloroquine diphosphate and the suspension, although the emission maximum is the same. We recommend more experimental study in the said direction, and by doing so, we feel that algorithm can be developed for quality control of chloroquine suspension by studying its fluorescence spectra without estimating chloroquine by tedious extraction–purification steps.

Acknowledgment

Sumanpreet Kaur and Dibyajyoti Banerjee acknowledge PGIMER, Chandigarh, for financial assistance. Monu Kumari acknowledges CSIR, New Delhi, India, for the award of fellowship (Dec. 2018). Sukhpreet Singh acknowledges UGC, India, for providing fellowship (F. No. 16-6(Dec. 2017)/2018(NET/CSIR). DK acknowledges CSIR, New Delhi, India, for providing fellowship (File No: 09/141 (0197)/2016-EMR-I).

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 1996;30:263-99.
2Johnston A, Holt DW. Substandard drugs: A potential crisis for public health. Br J Clin Pharmacol 2014;78:218-43.
3Newton PN, Caillet C, Guerin PJ. A link between poor quality antimalarials and malaria drug resistance? Expert Rev Anti Infect Ther 2016;14:531-3.
4Tackman EC, Trujillo MJ, Lockwood TL, Merga G, Lieberman M, Camden P. Identification of substandard and falsified antimalarial pharmaceuticals chloroquine, doxycycline, and primaquine using surface-enhanced Raman scattering. Anal Methods 2018;10:4718-22.
5Chen GQ, Wu YM, Wang J, Zhu T, Gao SM. Fluorescence spectroscopy study of synthetic food colors. Guang Pu Xue Yu Guang Pu Fen Xi 2009;29:2518-22.